MOR
$7.49
Morphosys Ag ADR
($.12)
(1.58%)
MOR
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  $0.00
Revenue:  N/A
Wednesday
Aug 2
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when MOR reports earnings?
Beat
Meet
Miss

Where is MOR's stock price going from here?
Up
Flat
Down
Stock chart of MOR
Analysts
Summary of analysts' recommendations for MOR
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
MorphoSys AG is a biopharmaceutical company. It develops treatment for cancer, inflammations and autoimmune diseases. The company's proprietary portfolio consists of MOR208, MOR202, MOR103, MOR106 and MOR107. Its partnered programs lighthouse project includes Tremfya(R) and Gantenerumab. MorphoSys AG is based in Planegg, Germany.
›